trending Market Intelligence /marketintelligence/en/news-insights/trending/VWmn7Wk3BlrCqFKKZ_ELAA2 content esgSubNav
In This List

LogicBio Therapeutics appoints 2 directors

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


LogicBio Therapeutics appoints 2 directors

LogicBio Therapeutics Inc. appointed Richard Moscicki and Michael Wyzga as directors.

Moscicki is the executive vice president for science and regulatory advocacy and the chief medical officer at Pharmaceutical Research and Manufacturers of America.

Wyzga is the CEO and president of MSW Consulting Inc., a private biotechnology consulting firm.

LogicBio Therapeutics is a genome-editing company that develops medicines for rare diseases in patients with unmet medical needs.